New eye drug shows promise for diabetic retinopathy in phase 2 trial
Disease control
Completed
This study tested a drug called faricimab in 179 adults with non-proliferative diabetic retinopathy, a diabetes-related eye condition that can lead to vision loss. The goal was to see if monthly injections of faricimab could improve blood flow in the retina over 48 weeks compared…
Phase: PHASE2 • Sponsor: Greater Houston Retina Research • Aim: Disease control
Last updated May 08, 2026 21:29 UTC